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A B S T R A C T
Background
Anxiety disorders are a common occurrence in today’s society. There is interest from the community in the use of complementary
therapies for anxiety disorders. This review examined the currently available evidence supporting the use of therapeutic touch in treating
anxiety disorders.
Objectives
To examine the efficacy and adverse effects of therapeutic touch for anxiety disorders.
Search methods
We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and
CCDANCTR-References) (search date 13/01/06), the Controlled Trials website and Dissertation Abstracts International. Searches of
reference lists of retrieved papers were also carried out and experts in the field were contacted.
Selection criteria
Inclusion criteria included all published and unpublished randomised and quasi-randomised controlled trials comparing therapeutic
touch with sham (mimic) TT, pharmacological therapy, psychological treatment, other treatment or no treatment /waiting list.The
participants included adults with an anxiety disorder defined by the Diagnostic and Statistical Manual (DSM-IV),the International
Classification of Diseases (ICD-10), validated diagnostic instruments, or other validated clinician or self-report instruments.
Data collection and analysis
Two review authors independently applied inclusion criteria. Further information was sought from trialists where papers contained
insufficant information to make a decision about eligibility.
Main results
No randomised or quasi-randomised controlled trials of therapeutic touch for anxiety disorders were identified.
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Authors’ conclusions
Given the high prevalence of anxiety disorders and the current paucity of evidence on therapeutic touch in this population, there is a
need for well conducted randomised controlled trials to examine the effectiveness of therapeutic touch for anxiety disorders.
P L A I N L A N G U A G E S U M M A R Y
Therapeutic touch for anxiety disorders
Anxiety disorders are a common occurrence in the general population and have considerable impact on quality of life. This review
aimed to assess the effectiveness of therapeutic touch on anxiety disorders. However no randomised controlled trials investigating the
effects of therapeutic touch for anxiety disorders were identified, and highlights the need for high quality randomised controlled trials
on this topic.
B A C K G R O U N D
Description of the condition
Anxiety disorders are classified by the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV, APA 1994) as acute stress
disorder, generalised anxiety disorder, post-traumatic stress disor-
der, obsessive-compulsive disorder, specific phobias, social anxi-
ety disorder and panic disorder. Each of these disorders is charac-
terised by uncontrollable and excessive worries, which may cause
poor concentration and physical symptoms. Anxiety disorders are
a common occurrence in modern society, with 12-month preva-
lence rates estimated at 17% and with a lifetime prevalence of al-
most 25% (Kessler 1994). As chronic disorders, they have consid-
erable impact on quality of life and have far reaching direct and
indirect economic consequences (Greenberg 1999). Variability in
the prevalence of specific anxiety disorders has been found between
different countries and cultures (Weissman 1997). Furthermore,
gender has been shown to impact on the prevalence of anxiety dis-
orders, with women being more likely than men to develop them
(Bijl 1998; Carter 2001; Wittchen 2002).
Description of the intervention
Psychological and pharmacological treatments are most com-
monly used in the treatment of anxiety disorders. Pharmacological
treatments include benzodiazepines, azapirones or antidepressants,
of which benzodiazepines are the most commonly used (Shader
1993). However, pharmacological therapy is often associated with
adverse side-effects (Lydiard 1997), with attitudes towards antide-
pressants consistently shown to be negative (Paykel 1998). There
are a range of psychological therapies which have been shown
to be effective and are commonly used to treat anxiety disorders
(Borkovec 1993), including cognitive behaviour therapy and sup-
portive psychotherapy and counselling. Nevertheless, psychologi-
cal therapies are often impracticable due to the time and resource
commitment required. Therefore, an effective and safe alternative
intervention would be a welcome addition to the current reper-
toire.
Therapeutic touch (TT) was first developed in the 1970s by Do-
lores Krieger, then a nursing professor at New York University and
Dora Kunz, a lay healer. Anxiety reduction, sometimes described
as relaxation, is frequently cited as an effect of TT (Sayre-Adams
2002; Olson 1997). Some research studies have reported that TT
can reduce anxiety in the elderly (Lin 1998) and in burn patients
(Turner 1998).Other studies have found no significant differences
in the reduction of anxiety when TT is compared to mimic TT
and routine treatment (Hale 1986).
How the intervention might work
The theoretical basis of contemporary TT is associated with the
Science of Unitary Human Beings theory (Rogers 1970). Rogers
views human beings as dynamic energy fields, and the world in
which human beings live as an energy system, and suggests that
there is a continual interaction within energy fields and with the
environment. Therapeutic touch is defined as the detecting and
balancing of energy. Imbalances and blockages in the energy field
lead to illness and ill health. Good health is experienced when the
flow of energy between the environment and the body is balanced
(Krieger 1997). Since this energy field extends beyond the skin,
physical touch is not required in order to practice TT.
The treatment involves two phases: assessment and balancing.
Practitioners initially centre themselves by becoming relaxed and
focused on the care about to be given, whilst the patient is en-
couraged to sit or lie comfortably. The practitioner moves their
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hands around the patient’s body, at a distance of two to five inches,
encountering and assessing the energy field by feeling for changes
in temperature, pressure, rhythm or a tingling sensation. The bal-
ancing phase involves the practitioner redirecting and rebalanc-
ing energy through the use of hand movements. This phase aims
to bring the two energy fields into a harmonic resonance. The
practitioner then ’smoothes’ out the patient’s energy field by run-
ning their hands from head to toe. The treatment is typically con-
cluded after 20 to 25 minutes or when the energy field is bal-
anced (Hagemaster 2000). The administration of multiple TT
treatments over a period of time appears to demonstrate a cumu-
lative effect (Peck 1998; Turner 1998).
Why is it important to do this review
Since the introduction of TT in 1974, when first taught by Do-
lores Krieger to a group of Masters degree students, it has gained
widespread support and is now reported to be taught in over 70
countries. Nevertheless, controversy still surrounds its effective-
ness. Most of the research to date has focused on the effectiveness
of TT in reducing anxiety, relieving pain and promoting healing
(Krieger 1993). Whilst some studies support the claim that TT
is effective (Heidt 1981; Kramer 1990), others have failed to do
this (Olson 1995). Rosa has reported evidence that discredits the
claims of TT and suggests that it should no longer be used by
professionals (Rosa 1998). Challenges to Rosa’s conclusions sug-
gest that inappropriate design and analysis led to inaccurate con-
clusions (Cox 2003; Tall 2003). However, a Cochrane review of
TT for healing acute wound healing found no evidence that it
promotes healing (O’Mathuna 2003).
To date there has been no systematic review to investigate the
strength of evidence for therapeutic touch in anxiety disorders.
This review aimed to provide a systematic summary of all currently
available evidence on the effectiveness and harms of TT for anxiety
disorders.
O B J E C T I V E S
To investigate the effectiveness and harms of therapeutic touch
(Krieger 1997) compared with one or a combination of the fol-
lowing:
(1) Sham (mimic) TT
(2) Pharmacological therapy
(3) Psychological treatment
(4) Other treatment
(5) No treatment or waiting list.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials and quasi-randomised trials (eg
randomisation using days of the week).
Types of participants
Adults (as defined by trialists) with anxiety disorders, diagnosed by
theDiagnostic and Statistical Manual (DSM-IV) (APA 1994), the
International Classification of Disease (ICD-10) (WHO 1992),
other validated diagnostic instruments, or other self-rated or clin-
ician-rated validated instruments that assess the level of anxiety
disorder symptoms, irrespective of gender, race or nationality.
Studies in which anxiety was a secondary symptom of a different
disorder (for example depression or other psychiatric diagnoses)
were excluded.
Types of interventions
Therapeutic touch in this review was defined as the detecting and
balancing of energy (Krieger 1997). Studies were included if:
(1) The intervention was described as therapeutic touch.
(2) Was underpinned by Rogers theory (The Science of Unitary
Human Beings).
(3) Was supported by appropriate references.
Therapies which were described as therapeutic touch (eg Reiki,
massage therapy) but did not meet the above criteria (2) and (3)
were excluded.
Comparison conditions were one or a combination of:
(1) Sham (mimic) TT, in which an individual mimics the gestures
used in the actual TT treatment whilst concentrating on another
activity, for example counting. There is no intention on the part
of the individual to facilitate the process of healing.
(2) Pharmacological treatment (eg anxiolytics or antidepressants).
(3) Psychological treatment (eg cognitive behavioural therapy, sup-
portive psychotherapy or counselling).
(4) Other treatment (eg massage).
(5) No treatment or waiting list.
Types of outcome measures
Trials were included if they used at least one of the following
outcomes:
Primary outcomes
(1) Reduction in anxiety symptoms, measured by self-rating scales
such as the trait subscale of the State Trait Anxiety Inventory (
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Spielberger 1983), PennStateWorryQuestionnaire (Meyer 1990),
the anxiety subscale of the Hospital Anxiety and Depression Scale
(HADS) (Zigmond 1983), the Beck Anxiety Inventory (BAI) (
Beck 1988) or by clinician-rated scales, such as the Hamilton
Rating Scale (Hamilton 1959).
(2) Subjective assessments whichmeasure a dichotomous outcome
(improvement versus no improvement) were included. The au-
thors do however recognise the possible bias within these measures
and if a difference was found in this outcome, greater reliance was
placed on the validated scales.
Symptom levels could be presented as continuous (mean and
standard deviation) or dichotomous outcomes (remission/recov-
ery versus non-remission/non-recovery).
Secondary outcomes
(1) Acceptability of therapeutic touch as a treatment (assessed by
questioning of participants, satisfaction measures or drop-outs).
(2) The number of people reporting adverse effects
(3) Change in use of medication
(4) Use of other support systems.
Search methods for identification of studies
See: Depression, Anxiety and Neurosis Group search strategy.
(1) Electronic searches
We searched theCochraneCollaborationDepression, Anxiety and
Neurosis Controlled Trials Registers (CCDANCTR-Studies and
CCDANCTR-References) (search date 13/01/06)
CCDANCTR-Studies
Diagnosis = Anxiety or Anxious or Agoraphobia or “Phobic Dis-
order*” or “Panic Disorder” or “Obsessive-Compulsive Disorder”
or “Post-Traumatic Stress Disorders”
and
Free-Text = touch
CCDANCTR-References
Keyword = Anxiety or Anxious or Agoraphobia or “Phobic Dis-
order*” or “Panic Disorder” or “Obsessive-Compulsive Disorder”
or “Post-Traumatic Stress Disorders”
and
Free-Text = touch
The Controlled Trials website was searched (www.controlled-tri-
als.com).
The following search terms were used:
Therapeutic Touch or Therapeutic Touch and Anxiety
Full text e-Journals
The Journal of Holistic Nursing
Terms used “Title=therapeutic touch”
1991-2006
(2) Reference lists
The reference lists of identified studies were inspected
(3) Personal communication
Personal communication with experts in the field took place. Pro-
fessional organisations contacted included the British Association
of Therapeutic Touch, the Nurse Healers Professional Association
(USA), Sacred Space Foundation (UK) and Therapeutic Touch
Network (Canada).
Data collection and analysis
Study selection
Abstracts of all publications obtained by the search strategy were
screened by two review authors for their relevance and design
according to the selection criteria. For abstracts where the authors
found any indication of a clinical trial, the full article was obtained
and assessed as to its relevance to this review. For articles written in
a language other than English, help was sought from theCochrane
Collaboration to translate and extract the data.
Methods for future updates
The review authors did not locate any studies which met the in-
clusion criteria for this review, but in future updates the following
methods are planned.
Quality assessment
Two independent review authors will assess the methodological
quality of the selected trials. In order to ensure that variation is not
caused by systematic errors in the design of a study, the method-
ological quality of the selected trials will be assessed by two inde-
pendent reviewers (JR and FB), using the criteria described in the
Cochrane Handbook. The criteria are based on the evidence of
a strong relationship between the potential for bias in the results
and allocation concealment (Schulz 1995) and are defined below
(Higgins 2005):
A. Adequate
B. Unclear
C. Inadequate
D. Allocation concealment not used.
Trials which meet A or B will be included.
Data extraction
Following an inclusion assessment, the methodology of the trial
will be assessed by two review authors independently (JR & FB).
Data will be extracted on individuals, methods, interventions,
outcomes and results. This data will be recorded on hard copy
datasheets, then entered into RevMan 4.2 (RevMan 2004). Miss-
ing data and clarification on aspects of study design/data will be
sought from the respective authors. When a disagreement cannot
be resolved through discussion, an arbitrator will be utilised (CC-
DAN editor).
Data analysis
Data types
Post-treatment outcomes will be assessed using dichotomous data
on remission of anxiety symptoms, and continuous data of anxiety
symptoms, using standardised measures.
Dichotomous data
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If dichotomous outcomes are presented, the cut-off points, des-
ignated by the authors as representing ’clinical improvement’ will
be identified and used to calculate a pooled relative risk (RR) and
95% confidence intervals (CI). If the author’s definitions of these
cut-off points are quite different, only those studies that have use
similar cut-off points (eg 20% reduction in scores) will be com-
bined into a pooled estimate. Where possible the number needed
to treat (NNT) with 95% confidence intervals will be calculated.
For each comparison a summary statistic of all those responding
to treatment will be calculated as a percentage of the total number
of participants.
Continuous data
For those completing trials, analysis of continuous data, based
on the random effects model, will be conducted. If normally dis-
tributed, continuous data, measured in different ways across stud-
ies but conceptually the same, will be pooled using the standard-
ised weighted mean difference (SMD). Where both endpoint and
change data are available for the same outcome, the endpoint will
be presented. Significance will be set at P< 0.05.
To ensure that the continuous measures data are normally dis-
tributed and that parametric tests can be used appropriately, the
following standards will be applied to all data prior to inclusion:
(1) Standard deviations and means are obtained from the article
or by contacting the author(s).
(2) For data with finite limits, such as the end point scale data, the
standard deviation (SD), when multiplied by two should be less
than themean. If this is not the case, then it would be unlikely that
the mean is an appropriate measure of central tendency (Altman
1996).
Data that are not normally distributed will be presented separately
in an ’Other data types’ table.
Fixed-effect model and random-effects model
If no evidence of heterogeneity is found, a fixed-effect model will
be used for both dichotomous and continuous data. A random-
effects model provides a more conservative estimate of effect and
will be used if statistical heterogeneity is found.
Testing for heterogeneity
The following two formal tests of heterogeneity will be used:
(1) The chi-squared test measures whether differences in effect
estimates between studies may have occured due to chance (a p-
value of 0.1 will be set, as the chi-squared test lacks power where
there are only a few studies for inclusion).
(2) The I-squared test measures the percentage of difference in
effect estimates between studies that is due to heterogeneity rather
than chance. A value greater then 50% is considered substantial
heterogeneity.
Sensitivity analyses
Sensitivity analyses will be performed to address the influence of
diagnosis or cut-off score on an anxiety scale as the diagnostic in-
clusion criterion, study quality (moderate/high), selection of scales
(self/observer rated measures), use of intention-to-treat analysis,
post randomisation exclusions and loss to follow up.
Subgroup analyses
Subgroup analyses will investigate whether:
(1)Trials which utilise different anxiety disorders differ in their
results.
(2)Trials which used different environmental settings differ in their
results.
(3)Trials which differ in the total number of TT sessions admin-
istered differ in their results.
Missing data
Intention-to-treat analysis of dichotomous outcome data will be
carried out, it will be assumed that participants who dropped out
had negative outcomes. For continuous outcomes end point data
will be used (including only participants with a final assessment)
or last observation carried forward (LOCF) if provided by trialists.
Tables and figures
Data relating to the training and experience of TT practitioners
will be presented in a table.
Publication bias
Data from all selected trials will be entered into a funnel plot to
investigate publication bias.
R E S U L T S
Description of studies
See: Characteristics of excluded studies.
Results of the search
A search of CCDANCTR-Studies and CCDANCTR-References
retrieved 11 references, representing for a total of 11 studies. Based
on the information provided in abstracts, full articles were ob-
tained all 11 studies and screened for eligibility by JR and FB.
Included studies
Following scrutiny of full articles that reported on the 11 studies,
none were deemed to meet all eligibility criteria for the review.
Excluded studies
Of 11 potential studies excluded from the review, one study was
excluded on the basis of non-randomisation of participants into
groups (Olson 1992).None of the 11 studies recruited populations
with an anxiety disorder diagnosis, with eight studies measuring
state anxiety rather than trait anxiety (Gagne 1994;Hale 1986; Lin
1998;Olson 1995 Parkes 1986;Quinn 1984;Quinn 1989; Turner
1998) as a response to hospitalisation and pain. In the study by
Larden 2004, patients with co-morbid psychiatric conditions were
recruited. All studies employed therapeutic touch in accordance
with the criteria set out under Types of intervention, with the
exception of the study byMcElligott 2003, inwhich touch therapy
was used.
Of the 11 studies excluded from the review, seven studied a pop-
ulation of hospitalised adults (Gagne 1994; Hale 1986; Larden
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2004; Parkes 1986; Quinn 1984; Quinn 1989; Turner 1998),
whilst the remaining four studied a population of nursing staff
(McElligott 2003), adults who had experienced Hurricane Hugo
(Olson 1992), healthy professional/student care givers (Olson
1995) and elderly individuals who attended community facilities
(Lin 1998).
Ongoing studies
Currently there are no ongoing randomised controlled trials ex-
amining therapeutic touch for anxiety disorders.
Risk of bias in included studies
No studies meeting all inclusion criteria for the review were lo-
cated.
Effects of interventions
No studies meeting all inclusion criteria for the review were lo-
cated.
D I S C U S S I O N
Summary of findings
This review showed that, to date, no randomised or quasi-ran-
domised controlled trials investigating the effects of therapeutic
touch (TT) on anxiety levels in anxiety disorders have been carried
out. A comprehensive search of electronic databases, reference lists
of relevant journal articles and personal communication with ex-
perts in the field was conducted, and it seems unlikely, therefore,
that we have simply ’missed’ relevant studies.
Since its introduction by Dolores Krieger in 1974, TT has gained
widespread support in over 70 countries. Nevertheless, whilst there
appears to be a small body of evidence examining the effectiveness
of therapeutic touch in the treatment of state anxiety, in response
to hospitalisation, medical procedures and pain, this systematic
review highlights the lack of studies investigating the effects of
therapeutic touch in reducing trait anxiety symptoms in patients
with anxiety disorders. We hope that studies of therapeutic touch
for anxiety disorders will become available for inclusion in future
updates of this review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Due to the lack of studies for inclusion in this review, it is not pos-
sible to draw any conclusions in terms of implications for practice.
Implications for research
Given the high prevalence of anxiety disorders, together with their
considerable personal and societal costs, the identification of ef-
fective interventions is clearly required. Complementary therapies
are popular as an alternative to pharmacological and psychological
therapies in treating anxiety disorders. This review highlights the
need for randomised controlled trials to evaluate the effectiveness
of therapeutic touch in reducing anxiety symptoms in people di-
agnosed with anxiety disorders. Future trials need to be rigorous
in design and delivery, with subsequent reporting to include high
quality descriptions of all aspects of methodology to enable ap-
praisal and interpretation of results.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Gagne 1994 Outcome measured - state anxiety
Hale 1986 Outcome measured - state anxiety
Larden 2004 co-morbid psychiatric condition
Lin 1998 Outcome measured - state anxiety
McElligott 2003 Alternative therapeutic touch intervention investigated
Olson 1992 Not a randomised controlled trial
Olson 1995 Outcome measured - state anxiety
Parkes 1986 Outcome measured - state anxiety
Quinn 1984 Outcome measured -state anxiety
Quinn 1989 Outcome measured - state anxiety
Turner 1998 Outcome measured - state anxiety
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